GI
RVMD icon

GAMMA Investing’s Revolution Medicines RVMD Stock Holding History

GAMMA Investing’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$465K Buy
2,266
+166
+8% +$32.9K 0.02% 740
2026
Q2 		$393K Buy
2,100
+501
+31% +$73.2K 0.01% 785
2026
Q1 		$156K Buy
1,599
+260
+19% +$26.3K 0.01% 1297
2025
Q4 		$107K Buy
1,339
+502
+60% +$32.9K 0.01% 1532
2025
Q3 		$39.1K Buy
837
+260
+45% +$10.2K ﹤0.01% 2152
2025
Q2 		$21.2K Sell
577
-25
-4% -$960 ﹤0.01% 2426
2025
Q1 		$21.3K Buy
602
+11
+2% +$447 ﹤0.01% 2341
2024
Q4 		$25.9K Sell
591
-29
-5% -$1.46K ﹤0.01% 2129
2024
Q3 		$28.1K Buy
620
+222
+56% +$9.67K ﹤0.01% 1897
2024
Q2 		$15.4K Buy
398
+142
+55% +$5.31K ﹤0.01% 2025
2024
Q1 		$8.25K Buy
256
+59
+30% +$1.75K ﹤0.01% 2159
2023
Q4 		$5.47K Buy
+197
New +$4.73K ﹤0.01% 2200

Other funds holding RVMD

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CGFA
Colton Groome Financial Advisors Asheville, North Carolina $427M AUM 13.21% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
BFS
Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

GAMMA Investing's RVMD Position: Q3 2026 in Review

GAMMA Investing increased its Revolution Medicines (RVMD) stake by 7.9% in Q3 2026, buying an estimated $32.9K and bringing the position to 2,266 shares worth $465K. The position accounts for 0.02% of the portfolio, ranked #740.

GAMMA Investing first reported a position in RVMD in Q4 2023 and has held it in 12 quarters since. 17 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • GAMMA Investing held 2,266 shares of Revolution Medicines worth $465K as of Q3 2026.
  • GAMMA Investing bought 166 Revolution Medicines shares in Q3 2026, an estimated $32.9K.
  • Revolution Medicines made up 0.02% of GAMMA Investing's portfolio in Q3 2026, its #740 holding.
  • GAMMA Investing first reported a position in Revolution Medicines in Q4 2023 and has held it in 12 quarters since.
  • 17 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.